TOVX
Theriva Biologics Inc.
NYSE MKT: TOVX · HEALTHCARE · BIOTECHNOLOGY
$0.36
+8.67% today
Updated 2026-04-30
Market cap
$16.23M
P/E ratio
—
P/S ratio
22.32x
EPS (TTM)
$-2.08
Dividend yield
—
52W range
$0 – $1
Volume
31.8M
Theriva Biologics Inc. (TOVX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.37M | $-6.61M | $-4.85M | $-2.92M | $-1.14M | $-2.88M | $-8.92M | $-7.72M | $-16.08M | $-38.89M | $-27.90M | $-20.20M | $-17.28M | $-13.87M | $-12.17M | $-12.89M | $-19.08M | $-19.00M | $-16.94M | $-16.67M |
| Capital expenditures | $45833.00 | $1.97M | $21398.00 | $1850.00 | $12663.00 | $0.00 | $10000.00 | $36000.00 | $48000.00 | $501000.00 | $569000.00 | $212000.00 | $7000.00 | $9000.00 | $9000.00 | $14000.00 | $116000.00 | $202000.00 | $1000.00 | $35000.00 |
| Depreciation | $30675.00 | $199629.00 | $404623.00 | $382089.00 | $358708.00 | $201000.00 | $63000.00 | $43000.00 | $20000.00 | $72000.00 | $157000.00 | $245000.00 | $272000.00 | $240000.00 | $201000.00 | $87000.00 | $85000.00 | $135000.00 | $137000.00 | — |
| Stock-based comp | — | $2.08M | $1.28M | $323936.00 | $660649.00 | $1.23M | $1.85M | $1.67M | $2.46M | $3.20M | $4.01M | $3.41M | $2.07M | $340000.00 | $350000.00 | $416000.00 | $475000.00 | $552000.00 | $671000.00 | $654000.00 |
| Free cash flow | $-2.41M | $-8.57M | $-4.87M | $-2.92M | $-1.15M | $-2.88M | $-8.93M | $-7.75M | $-16.13M | $-39.39M | $-28.47M | $-20.42M | $-17.29M | $-13.88M | $-12.18M | $-12.90M | $-19.20M | $-19.20M | $-16.94M | $-16.70M |
| Investing cash flow | $-710833.00 | $-1.97M | $110867.00 | $-172167.00 | $64597.00 | $-75000.00 | $-10000.00 | $-36000.00 | $-48000.00 | $-501000.00 | $-569000.00 | $-212000.00 | $-7000.00 | $-9000.00 | $-9000.00 | $-14000.00 | $-4.40M | $-202000.00 | $-1000.00 | — |
| Financing cash flow | $14.11M | $7.87M | $-895610.00 | $-50310.00 | $1.01M | $6.98M | $12.20M | $12.43M | $19.03M | $42.68M | $26.71M | $18.48M | $29.09M | $3.36M | $3.36M | $74.00M | $-1.93M | $625000.00 | $5.50M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |